Discovery of Biaryl Amides as Potent, Orally Bioavailable, and CNS Penetrant RORγt InhibitorsYonghui Wang, Xichen Lin, Qian Liu et al.|ACS Medicinal Chemistry Letters|2015Cited by 76
BET degrader exhibits lower antiproliferative activity than its inhibitor via EGR1 recruiting septins to promote E2F1-3 transcription in triple-negative breast cancerNan Liu, Quan Liu, Shuai Wang et al.|Pharmacological Research|2024Cited by 6